Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet need.
Our product portfolio currently comprises 25 marketed treatments in the United States. These include a number of category firsts and market leaders in various therapeutic areas.
Gilead has more than 11,000 employees.
Gilead is incorporated in the State of Delaware.
Gilead went public in January 1992.